Bruker Corporation (NasdaqGS:BRKR) entered into an agreement to acquire Substantially all assets from NanoString Technologies, Inc. (OTCPK:NSTG.Q), NanoString Technologies Germany GmbH, Nanostring Technologies International, Inc. and NanoString Technologies Netherlands B.V. for approximately $390 million on April 16, 2024. In 2023, NanoString generated revenues of approximately $168 million. Bruker expects to fund the acquisition with cash on hand and established debt instruments. Following the closing, the NanoString business will become part of the Bruker Spatial Biology business. The agreement is subject to Bankruptcy Court approval and other customary closing conditions. The transaction is expected to close in early-May. On April 19, 2024, the transaction was approved under a court-supervised Chapter 11 sale process pursuant to Section 363 of the U.S. Bankruptcy Code, and it is expected to close in the second quarter of 2024, subject to customary closing conditions. Rachel Strickland, Thomas Mark, Debra Sinclair and Tyler Born of Willkie Farr & Gallagher LLP acted as legal advisor to NanoString Technologies. Rachel C. Strickland and Debra M. Sinclair of Morgan, Lewis & Bockius LLP acted as legal advisor to Bruker Corp. Goldman Sachs & Co. LLC acted as financial advisor to Bruker Corp.

Bruker Corporation (NasdaqGS:BRKR) completed the acquisition of Substantially all assets from NanoString Technologies, Inc. (OTCPK:NSTG.Q), NanoString Technologies Germany GmbH, Nanostring Technologies International, Inc. and NanoString Technologies Netherlands B.V. on May 6, 2024.